Browse by Employee ID
![[up]](/style/images/multi_up.png)
Up a levelNumber of items: 1.
Shalini, C and Priyanga, J (2026) Advancing ER-positive breast cancer risk reduction from traditional SERMs to heterocyclic scaffolds and dual SERM-SERD combinations”. In: Association of Pharmacy Professionals INDO KOREAN INTERNATIONAL BRANCH.